Dachaigh › Lymphoma › Ohio › Cleveland
Sgrùdaidhean clionaigeach Lymphoma ann an Cleveland, OH
Tha 14 sgrùdaidhean airson Lymphoma a’ lorg phàirtichean aig làraichean ann agus timcheall air Cleveland (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.
Teacsa sgrùdaidh oifigeil (Beurla)
A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →
T-Cell Therapy (EB103) in Adults With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (NHL)
A’ fastadhÌre 1/2
- University Hospitals Seidman Cancer Center, Cleveland
A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
A’ fastadhÌre 1
- University Hospitals Cleveland Medical Center, Cleveland
A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy in Adults With Transplant-Ineligible Primary Central Nervous System Lymphoma
A’ fastadhÌre 2
- Cleveland Clinic, Cleveland
A Study to Evaluate the Safety and Pharmacokinetics of Eflapegrastim in Pediatric Participants With Solid Tumors or Lymphomas and Treated With Myelosuppressive Chemotherapy
A’ fastadhÌre 2
- University Hospitals Cleveland Medical Center, Cleveland
A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)
A’ fastadhÌre 2
- The Cleveland Clinic Foundation, Cleveland
Surovatamig as Consolidation Therapy in Participants With Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated Immunoglobulin Heavy Chain Variable (IGHV)
A’ fastadhÌre 3
- Research Site, Cleveland
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
A’ fastadhÌre 1/2
- Cleveland Clinic, Cleveland
A Study of REC-1245 in Participants With Unresectable, Locally Advanced, or Metastatic Cancer
A’ fastadhÌre 1/2
- Cleveland Clinic, Cleveland
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
A’ fastadhÌre 3
- Cleveland Clinical Taussig Cancer Center, Cleveland
A Study of ELA026 in Participants With Relapsed/Refractory (R/R) T/NK Cell Malignancies (TCMs)
A’ fastadhÌre 1
- University Hospitals Cleveland Medical Center, Cleveland
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
A’ fastadhÌre 1
- Cleveland Clinic, Cleveland
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
A’ fastadhÌre 1/2
- Cleveland Clinic, Cleveland
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
- Cleveland Clinic, Cleveland
Phase 1 Study of BAFF CAR-T Cells (LMY-920) for Treatment of Relapsed or Refractory Chronic Lymphocytic Leukemia / Small Lymphocytic Lymphoma
A’ fastadhÌre 1
- Case Comprehensive Cancer Center, Cleveland Clinic Foundation Taussig Cancer Institute, Cleveland
Sgrùdaidhean Lymphoma ann am bailtean eile
- Houston, TX34 sgrùdaidhean
- Boston, MA33 sgrùdaidhean
- New York City, NY33 sgrùdaidhean
- Washington, DC23 sgrùdaidhean
- Baldwin Park, CA21 sgrùdaidhean
- Chicago, IL20 sgrùdaidhean
- Durham, NC17 sgrùdaidhean
- St. Louis, MO15 sgrùdaidhean
- Philadelphia, PA15 sgrùdaidhean
- Edison, NJ12 sgrùdaidhean
- Atlanta, GA12 sgrùdaidhean
- Seattle, WA12 sgrùdaidhean
Sgrùdaidhean eile ann an Cleveland
- Aillse Sgamhain Neo-chealla-beag43 sgrùdaidhean
- Aillse (gach seòrsa)36 sgrùdaidhean
- Aillse a' bhroilleach35 sgrùdaidhean
- Aillse Prostata34 sgrùdaidhean
- Fàilligeadh a' Chridhe33 sgrùdaidhean
- Ailse metastatach30 sgrùdaidhean
- Cancer Ovarian30 sgrùdaidhean
- Ailseachadh nan Sgamhan26 sgrùdaidhean
- Aillse colorectal24 sgrùdaidhean
- Galarachd Cardiovasculach22 sgrùdaidhean
- Ailse Endometrial20 sgrùdaidhean
- Leukemia myeloid geur20 sgrùdaidhean
Bho ClinicalTrials.gov, dàta air a thogail 5 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.